VBIZF (Viva Biotech Holdings) Other Stockholders Equity : $51.3 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Other Stockholders Equity?

Viva Biotech Holdings's Other Stockholders Equity for the quarter that ended in Dec. 2023 was $51.3 Mil.

Viva Biotech Holdings's quarterly Other Stockholders Equity increased from Dec. 2022 ($53.9 Mil) to Jun. 2023 ($57.3 Mil) but then declined from Jun. 2023 ($57.3 Mil) to Dec. 2023 ($51.3 Mil).

Viva Biotech Holdings's annual Other Stockholders Equity increased from Dec. 2021 ($21.5 Mil) to Dec. 2022 ($53.9 Mil) but then declined from Dec. 2022 ($53.9 Mil) to Dec. 2023 ($51.3 Mil).

Viva Biotech Holdings Other Stockholders Equity Historical Data

The historical data trend for Viva Biotech Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Other Stockholders Equity Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

253.38

582.51

21.54

53.91

51.34

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Stockholders Equity	Get a 7-Day Free Trial										607.16	53.91	57.32	51.34	-

Viva Biotech Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Viva Biotech Holdings Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (OTCPK:VBIZF) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

01873:Hong Kong VB0:Germany

Address

735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website

https://www.vivabiotech.com

Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.